Lupin will fund the buy through $100 mn cash reserves and a bridge loan.
US country head, key departmental heads leave; more likely to follow.
On BSE, 1,469 shares fell and 1,200 shares rose. A total of 190 shares were unchanged.
The test used now, called PCR (or polymerace chain reaction), uses a nasal or throat swab sample and identifies the virus. These tests take at least five hours to give results. The rapid test, on the other hand, uses a blood sample and gives results based on detecting the presence of certain antibodies that react to the coronavirus protein.
Trump attributed the spike in the confirmed cases of coronavirus to the large-scale testing of the deadly disease.
Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.
Addressing a press briefing, health ministry Joint Secretary Lav Agarwal said currently there are no approved therapies for COVID-19 and there is not enough evidence to claim that plasma therapy can be used for treatment of the disease.
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
Expectations of strong results, consistent performance and investors preference for stocks in the defensive space help the sector outshine broader markets.
Financials were the top losers while oil shares also declined amid weak crude oil prices.
The percentage of non-standard quality drugs in the state has been in the range of 2-2.5% as compared to an all-India average of 5-6%
An overarching law governing public healthcare is a glaring gap in India's fight against the COVID-19 pandemic. In India it is left to individuals to quarantine themselves voluntarily. Moreover, the 123-year old The Epidemic Diseases Act, 1897, governs healthcare emergencies in India.
Benchmark indices finished higher on hopes of economic reforms
The top gainers on the Sensex are Gail(India), HDFC, Infosys.
Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.
In the last one week several companies have had to face the hurdle of making a distinction between what's essential and what's not. To help them the government has now clarified that grocery would include hygiene products such as hand wash, soaps, disinfectants, body wash, shampoo, surface cleaners, detergents, tissue paper, toothpaste, oral care, sanitary pads, diapers, chargers and battery cells, etc.
Samvat 2072: Auto sector could see faster recovery
A recent survey revealed that 46 percent of girls and 30 percent of boys in the US, most of who are in their teens smoke to control their weight.
Singh brothers might be stopped by 'fit & proper' hurdle due to US drug norm violations; firm says confident of qualifying.
Nestle now has less than two weeks to convince the regulator why product approval for its noodles should not be withdrawn
Over 3,66,000 Americans have tested positive for the deadly coronavirus.
Torrent to buy Ranbaxy's anti-bacterial generic
Midcap stocks continued to remain on buyers' radar with BSE Midcap index up 0.1%.
Sensex,Nifty to remain under pressure through the week.
In the longest losing streak of 2017, the BSE Sensex has lost 1,270 points, or 3.91 per cent. It fell to a three-month low of 31,154.03 on Wednesday.
Nestle refused to regret the mistake in a public statement.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Jammu and Kashmir MLA Ramesh Arora wants momos banned, but are they really unhygienic and harmful?
Apart from Maggi noodles, many other products can be tested for health issues.
The top gainers on the Sensex were Cipla, Bharti Airtel, Maruti Suzuki, Hero Moto & Sesa Sterlite.
The S&P BSE Sensex ended down 371 points at 24,966 and the Nifty50 closed 101 points lower at 7,615.
The complaint is against Nestle's 'unfair trade practices'.
The winter session of Parliament will commence on November 26.
Analysts say those taking exposure through stocks could look at firms focused on domestic business
'Indian doctors have also been wary of patients learning about drugs and brand names.' 'Probably harking back to the Brahmanical tradition of preserving information and knowledge from getting polluted by the lower classes,' says Ambi Parameswaran.
Indian markets ended on a lower note after the stimulus announced by the European Central Bank (ECB) failed to meet expectation.
HSBC maintained "overweight" rating on Indian equities, saying "fundamentals are strong".
Fear factors weights on markets, Sensex, Nifty struggle to keep pace.
FIIs are looking at the long-term story and initiatives of Indian pharma companies to transform themselves into global entities.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances